{"id":27641,"date":"2021-10-19T14:27:04","date_gmt":"2021-10-19T13:27:04","guid":{"rendered":"https:\/\/faus-moliner.com\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/"},"modified":"2021-10-19T15:34:35","modified_gmt":"2021-10-19T14:34:35","slug":"ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante","status":"publish","type":"post","link":"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/","title":{"rendered":"Ofertas a hospitales ante la aparici\u00f3n de gen\u00e9ricos o biosimilares y la definici\u00f3n de mercado relevante"},"content":{"rendered":"\n<p>On April 20, 2021, the Spanish Competition Authority decided to take no further action against a complaint filed by Amgen against Abbvie for an alleged abuse of a dominant position contrary to articles 2 of the Spanish Law on Competition and 102 of the TFEU.<\/p>\n\n\n\n<p>The alleged abusive practice consisted in the implementation of a commercial strategy of exclusionary discounts offered by Abbvie to hospitals in the sale of Humira\u00ae, which according to the complainant made it difficult difficult for biosimilars to enter the market. The Spanish Competition Authority dismissed the complaint.<\/p>\n\n\n\n<p>Its ruling is interesting as regards market definition and how the Spanish Competition Authority intends to analyze commercial offers made by companies holding a dominant position in the relevant market.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On April 20, 2021, the Spanish Competition Authority decided to take no further action against a complaint filed by Amgen against Abbvie for an alleged abuse of a dominant position contrary to articles 2 of the Spanish Law on Competition and 102 of the TFEU. The alleged abusive practice consisted in the implementation of a&#8230; <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/\" class=\"excerpt-read-more\">Read More<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[71],"tags":[],"coauthors":[528,105],"class_list":["post-27641","post","type-post","status-publish","format-standard","hentry","category-publications"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ofertas a hospitales ante la aparici\u00f3n de gen\u00e9ricos o biosimilares y la definici\u00f3n de mercado relevante - Faus Moliner<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ofertas a hospitales ante la aparici\u00f3n de gen\u00e9ricos o biosimilares y la definici\u00f3n de mercado relevante - Faus Moliner\" \/>\n<meta property=\"og:description\" content=\"On April 20, 2021, the Spanish Competition Authority decided to take no further action against a complaint filed by Amgen against Abbvie for an alleged abuse of a dominant position contrary to articles 2 of the Spanish Law on Competition and 102 of the TFEU. The alleged abusive practice consisted in the implementation of a... Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/\" \/>\n<meta property=\"og:site_name\" content=\"Faus Moliner\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-19T13:27:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-19T14:34:35+00:00\" \/>\n<meta name=\"author\" content=\"Laura Marqu\u00e8s, Jordi Faus\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Laura Marqu\u00e8s, Jordi Faus\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/\"},\"author\":{\"name\":\"Jordi Faus\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260\"},\"headline\":\"Ofertas a hospitales ante la aparici\u00f3n de gen\u00e9ricos o biosimilares y la definici\u00f3n de mercado relevante\",\"datePublished\":\"2021-10-19T13:27:04+00:00\",\"dateModified\":\"2021-10-19T14:34:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/\"},\"wordCount\":137,\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"articleSection\":[\"Publications\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/\",\"url\":\"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/\",\"name\":\"Ofertas a hospitales ante la aparici\u00f3n de gen\u00e9ricos o biosimilares y la definici\u00f3n de mercado relevante - Faus Moliner\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\"},\"datePublished\":\"2021-10-19T13:27:04+00:00\",\"dateModified\":\"2021-10-19T14:34:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/faus-moliner.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ofertas a hospitales ante la aparici\u00f3n de gen\u00e9ricos o biosimilares y la definici\u00f3n de mercado relevante\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"name\":\"faus-moliner.com\",\"description\":\"Otro sitio realizado con WordPress\",\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/faus-moliner.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\",\"name\":\"Faus Moliner\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"contentUrl\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"width\":400,\"height\":283,\"caption\":\"Faus Moliner\"},\"image\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/2372042\/admin\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260\",\"name\":\"Jordi Faus\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/f7cb308a9e6d6fe5434c7ca47ff11be5\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g\",\"caption\":\"Jordi Faus\"},\"description\":\"Jordi Faus graduated in Law at the Autonomous University of Barcelona (1986) and obtained a degree in Advanced Legal European Studies at the College of Europe in Bruges, Belgium (1987). He also has completed an Executive Management Programme at IESE Business School, in Barcelona.\",\"sameAs\":[\"https:\/\/faus-moliner.com\/\"],\"url\":\"https:\/\/faus-moliner.com\/en\/author\/jordi-faus\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ofertas a hospitales ante la aparici\u00f3n de gen\u00e9ricos o biosimilares y la definici\u00f3n de mercado relevante - Faus Moliner","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/","og_locale":"en_US","og_type":"article","og_title":"Ofertas a hospitales ante la aparici\u00f3n de gen\u00e9ricos o biosimilares y la definici\u00f3n de mercado relevante - Faus Moliner","og_description":"On April 20, 2021, the Spanish Competition Authority decided to take no further action against a complaint filed by Amgen against Abbvie for an alleged abuse of a dominant position contrary to articles 2 of the Spanish Law on Competition and 102 of the TFEU. The alleged abusive practice consisted in the implementation of a... Read More","og_url":"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/","og_site_name":"Faus Moliner","article_published_time":"2021-10-19T13:27:04+00:00","article_modified_time":"2021-10-19T14:34:35+00:00","author":"Laura Marqu\u00e8s, Jordi Faus","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Laura Marqu\u00e8s, Jordi Faus","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/#article","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/"},"author":{"name":"Jordi Faus","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260"},"headline":"Ofertas a hospitales ante la aparici\u00f3n de gen\u00e9ricos o biosimilares y la definici\u00f3n de mercado relevante","datePublished":"2021-10-19T13:27:04+00:00","dateModified":"2021-10-19T14:34:35+00:00","mainEntityOfPage":{"@id":"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/"},"wordCount":137,"publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"articleSection":["Publications"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/","url":"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/","name":"Ofertas a hospitales ante la aparici\u00f3n de gen\u00e9ricos o biosimilares y la definici\u00f3n de mercado relevante - Faus Moliner","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/#website"},"datePublished":"2021-10-19T13:27:04+00:00","dateModified":"2021-10-19T14:34:35+00:00","breadcrumb":{"@id":"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/faus-moliner.com\/en\/ofertas-a-hospitales-ante-la-aparicion-de-genericos-o-biosimilares-y-la-definicion-de-mercado-relevante\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/faus-moliner.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ofertas a hospitales ante la aparici\u00f3n de gen\u00e9ricos o biosimilares y la definici\u00f3n de mercado relevante"}]},{"@type":"WebSite","@id":"https:\/\/faus-moliner.com\/en\/#website","url":"https:\/\/faus-moliner.com\/en\/","name":"faus-moliner.com","description":"Otro sitio realizado con WordPress","publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/faus-moliner.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/faus-moliner.com\/en\/#organization","name":"Faus Moliner","url":"https:\/\/faus-moliner.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","contentUrl":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","width":400,"height":283,"caption":"Faus Moliner"},"image":{"@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/2372042\/admin\/"]},{"@type":"Person","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260","name":"Jordi Faus","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/f7cb308a9e6d6fe5434c7ca47ff11be5","url":"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g","caption":"Jordi Faus"},"description":"Jordi Faus graduated in Law at the Autonomous University of Barcelona (1986) and obtained a degree in Advanced Legal European Studies at the College of Europe in Bruges, Belgium (1987). He also has completed an Executive Management Programme at IESE Business School, in Barcelona.","sameAs":["https:\/\/faus-moliner.com\/"],"url":"https:\/\/faus-moliner.com\/en\/author\/jordi-faus\/"}]}},"_links":{"self":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/27641","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/comments?post=27641"}],"version-history":[{"count":10,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/27641\/revisions"}],"predecessor-version":[{"id":27656,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/27641\/revisions\/27656"}],"wp:attachment":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/media?parent=27641"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/categories?post=27641"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/tags?post=27641"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/coauthors?post=27641"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}